CD40 ligand preferentially modulates immune response and enhances protection against influenza virus

Journal of Immunology

Volumn 193, Issue 2, 2014, Pages 722-734

  Hashem, Anwar M ^a,b   Gravel, Caroline ^a   Chen, Ze ^c   Yi, Yinglei ^c   Tocchi, Monika ^a   Jaentschke, Bozena ^a   Fan, Xingliang ^d   Li, Changgui ^d   Rosu Myles, Michael ^a   Pereboev, Alexander ^e,f,g   He, Runtao ^h   Wang, Junzhi ^d   Li, Xuguang ^a,i  

^a HEALTH CANADA   (Canada)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c Shanghai Institute of Biological Products   (China)

^d NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^e and Clinical Center   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^h PUBLIC HEALTH AGENCY OF CANADA   (Canada)

ⁱ UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD4 ANTIGEN; CD40 LIGAND; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; INFLUENZA VACCINE; RECOMBINANT SECRETED NUCLEOPROTEIN; RECOMBINANT SECRETED NUCLEOPROTEIN CD40L FUSION PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; FEMALE; GENE REARRANGEMENT; GERMINAL CENTER; HOST RESISTANCE; IMMUNOMODULATION; IN VITRO STUDY; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SINGLE DRUG DOSE; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

ADAPTIVE IMMUNITY; ADENOVIRIDAE; ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; DOGS; FEMALE; GENETIC VECTORS; HEK293 CELLS; HUMANS; IMMUNIZATION; INFLUENZA A VIRUS; MADIN DARBY CANINE KIDNEY CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NIH 3T3 CELLS; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE INFECTIONS; RECOMBINANT FUSION PROTEINS; SURVIVAL ANALYSIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84904267797     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300093     Document Type: Article

References (65)

1. Kovacsovics-Bankowski, M., K. Clark, B. Benacerraf, and K. L. Rock. 1993. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA 90:4942-4946. (Pubitemid 23182951)
2. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Théry, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20: 621-667. (Pubitemid 34293436)
3. Whitmire, J. K., and R. Ahmed. 2000. Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) T cell responses. Curr. Opin. Immunol. 12: 448-455. (Pubitemid 30410352)
4. van Kooten, C., and J. Banchereau. 2000. CD40-CD40 ligand. J. Leukoc. Biol. 67: 2-17. (Pubitemid 30046812)
5. Bishop, G. A., and B. S. Hostager. 2003. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev. 14: 297-309.
6. Quezada, S. A., L. Z. Jarvinen, E. F. Lind, and R. J. Noelle. 2004. CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 22: 307-328. (Pubitemid 38680425)
7. Ma, D. Y., and E. A. Clark. 2009. The role of CD40 and CD154/CD40L in dendritic cells. Semin. Immunol. 21: 265-272.
8. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393: 478-480.
9. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483.
10. Ahmed, K. A., L. Wang, M. A. Munegowda, S. J. Mulligan, J. R. Gordon, P. Griebel, and J. Xiang. 2012. Direct in vivo evidence of CD4+ T cell requirement for CTL response and memory via pMHC-I targeting and CD40L signaling. [Published erratum appears in 2012 J. Leukoc. Biol. 92: 1123.] J. Leukoc. Biol. 92: 289-300.
11. Schultze, J. L., S. Michalak, M. J. Seamon, G. Dranoff, K. Jung, J. Daley, J. C. Delgado, J. G. Gribben, and L. M. Nadler. 1997. CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J. Clin. Invest. 100: 2757-2765. (Pubitemid 28007544)
12. Lapointe, R., A. Bellemare-Pelletier, F. Housseau, J. Thibodeau, and P. Hwu. 2003. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Res. 63: 2836- 2843.
13. Mendoza, R. B., M. J. Cantwell, and T. J. Kipps. 1997. Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization. J. Immunol. 159: 5777-5781. (Pubitemid 127471510)
14. Gurunathan, S., K. R. Irvine, C. Y. Wu, J. I. Cohen, E. Thomas, C. Prussin, N. P. Restifo, and R. A. Seder. 1998. CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J. Immunol. 161: 4563-4571. (Pubitemid 28492028)
15. Tripp, R. A., L. Jones, L. J. Anderson, and M. P. Brown. 2000. CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse. J. Immunol. 164: 5913-5921. (Pubitemid 30389838)
16. Sin, J. I., J. J. Kim, D. Zhang, and D. B. Weiner. 2001. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo. Hum. Gene Ther. 12: 1091-1102. (Pubitemid 32692424)
17. Zheng, M., A. J. Ramsay, M. B. Robichaux, K. A. Norris, C. Kliment, C. Crowe, R. R. Rapaka, C. Steele, F. McAllister, J. E. Shellito, et al. 2005. CD4+ T cellindependent DNA vaccination against opportunistic infections. J. Clin. Invest. 115: 3536-3544. (Pubitemid 43121841)
18. Gómez, C. E., J. L. Nájera, R. Sánchez, V. Jiménez, and M. Esteban. 2009. Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIVantigens. Vaccine 27: 3165-3174.
19. Cao, J., X. Wang, Y. Du, Y. Li, X. Wang, and P. Jiang. 2010. CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine. Vaccine 28: 7514-7522.
20. Auten, M. W., W. Huang, G. Dai, and A. J. Ramsay. 2012. CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals. Vaccine 30: 2768-2777.
21. Manoj, S., P. J. Griebel, L. A. Babiuk, and S. van Drunen Littel-van den Hurk. 2004. Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154. Immunology 112: 328-338. (Pubitemid 38703579)
22. Pereboev, A. V., J. M. Nagle, M. A. Shakhmatov, P. L. Triozzi, Q. L. Matthews, Y. Kawakami, D. T. Curiel, and J. L. Blackwell. 2004. Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule. Mol. Ther. 9: 712-720. (Pubitemid 38660424)
23. Huang, D., A. V. Pereboev, N. Korokhov, R. He, L. Larocque, C. Gravel, B. Jaentschke, M. Tocchi, W. L. Casley, M. Lemieux, et al. 2008. Significant alterations of biodistribution and immune responses in Balb/c mice administered with adenovirus targeted to CD40(+) cells. Gene Ther. 15: 298-308. (Pubitemid 351223466)
24. Lin, F. C., Y. Peng, L. A. Jones, P. H. Verardi, and T. D. Yilma. 2009. Incorporation of CD40 ligand into the envelope of pseudotyped single-cycle Simian immunodeficiency viruses enhances immunogenicity. J. Virol. 83: 1216-1227.
25. Hangalapura, B. N., D. Oosterhoff, S. Aggarwal, P. G. J. T. B. Wijnands, R. van de Ven, S. J. A. M. Santegoets, M. P. van den Tol, E. Hooijberg, A. Pereboev, A. J. M. van den Eertwegh, et al. 2010. Selective transduction of dendritic cells in human lymph nodes and superior induction of high-avidity melanoma-reactive cytotoxic T cells by a CD40-targeted adenovirus. J. Immunother. 33: 706-715.
26. Yao, Q., K. P. Fischer, L. Li, B. Agrawal, Y. Berhane, D. L. Tyrrell, K. S. Gutfreund, and J. Pasick. 2010. Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40L) in Pekin ducks. Vaccine 28: 8147-8156.
27. Kim, Y.-S., Y.-J. Kim, J.-M. Lee, S.-H. Han, H.-J. Ko, H.-J. Park, A. Pereboev, H. H. Nguyen, and C.-Y. Kang. 2010. CD40-targeted recombinant adenovirus significantly enhances the efficacy of antitumor vaccines based on dendritic cells and B cells. Hum. Gene Ther. 21: 1697-1706.
28. Franco, D., W. Liu, D. F. Gardiner, B. H. Hahn, and D. D. Ho. 2011. CD40L-containing virus-like particle as a candidate HIV-1 vaccine targeting dendritic cells. J. Acquir. Immune Defic. Syndr. 56: 393-400.
29. Hangalapura, B. N., D. Oosterhoff, J. de Groot, L. Boon, T. Tüting, A. J. van den Eertwegh, W. R. Gerritsen, V. W. van Beusechem, A. Pereboev, D. T. Curiel, et al. 2011. Potent antitumor immunity generated by a CD40-targeted adenoviral vaccine. Cancer Res. 71: 5827-5837.
30. Sánchez Ramos, O., A. González Pose, S. Gómez-Puerta, J. Noda Gomez, A. Vega Redondo, J. C. Águila Benites, L. Suárez Amarán, N. C. Parra, and J. R. Toledo Alonso. 2011. Avian CD154 enhances humoral and cellular immune responses induced by an adenovirus vector-based vaccine in chickens. Comp. Immunol. Microbiol. Infect. Dis. 34: 259-265.
31. Hashem, A., T. M. Doyle, G. Van Domselaar, A. Farnsworth, C. Li, J. Wang, R. He, and X. Li. 2011. Recent developments in bioinformatics analyses of influenza A virus surface glycoproteins and their biological relevance. Curr. Bioinform. 6: 415-426.
32. Fu, T. M., A. Friedman, J. B. Ulmer, M. A. Liu, and J. J. Donnelly. 1997. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J. Virol. 71: 2715-2721. (Pubitemid 27119908)
33. Epstein, S. L., W.-P. Kong, J. A. Misplon, C.-Y. Lo, T. M. Tumpey, L. Xu, and G. J. Nabel. 2005. Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. Vaccine 23: 5404-5410. (Pubitemid 41579312)
34. Laddy, D. J., J. Yan, A. S. Khan, H. Andersen, A. Cohn, J. Greenhouse, M. Lewis, J. Manischewitz, L. R. King, H. Golding, et al. 2009. Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus. J. Virol. 83: 4624-4630.
35. Patel, A., K. Tran, M. Gray, Y. Li, Z. Ao, X. Yao, D. Kobasa, and G. P. Kobinger. 2009. Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses. Vaccine 27: 3083-3089.
36. Rao, S. S., W.-P. Kong, C.-J. Wei, N. Van Hoeven, J. P. Gorres, M. Nason, H. Andersen, T. M. Tumpey, and G. J. Nabel. 2010. Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret. PLoS ONE 5: e9812.
37. Hashem, A., B. Jaentschke, C. Gravel, M. Tocchi, T. Doyle, M. Rosu-Myles, R. He, and X. Li. 2012. Subcutaneous immunization with recombinant adenovirus expressing influenza A nucleoprotein protects mice against lethal viral challenge. Hum. Vaccin. Immunother. 8: 425-430.
38. Flaman, A. S., C. Gravel, A. M. Hashem, M. Tocchi, and X. Li. 2011. The effect of interferon-α on the expression of cytochrome P450 3A4 in human hepatoma cells. Toxicol. Appl. Pharmacol. 253: 130-136.
39. Hauser, H., L. Shen, Q.-L. Gu, S. Krueger, and S.-Y. Chen. 2004. Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines. Gene Ther. 11: 924-932. (Pubitemid 38786607)
40. Gravel, C., C. Li, J. Wang, A. M. Hashem, B. Jaentschke, K.-W. Xu, B. Lorbetskie, G. Gingras, Y. Aubin, G. Van Domselaar, et al. 2010. Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences. Vaccine 28: 5774-5784.
41. Walzl, G., S. Tafuro, P. Moss, P. J. Openshaw, and T. Hussell. 2000. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. J. Exp. Med. 192: 1317-1326.
42. Heer, A. K., A. Shamshiev, A. Donda, S. Uematsu, S. Akira, M. Kopf, and B. J. Marsland. 2007. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J. Immunol. 178: 2182-2191. (Pubitemid 46233416)
43. + T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in longterm latently infected individuals. Eur. J. Immunol. 41: 2925-2936.
44. Hashem, A. M., A. S. Flaman, A. Farnsworth, E. G. Brown, G. Van Domselaar, R. He, and X. Li. 2009. Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases. PLoS ONE 4: e8350.
45. Prokudina, E. N., N. P. Semenova, V. M. Chumakov, I. A. Rudneva, and S. S. Yamnikova. 2001. Extracellular truncated influenza virus nucleoprotein. Virus Res. 77: 43-49. (Pubitemid 32622809)
46. Watanabe, H., K. Numata, T. Ito, K. Takagi, and A. Matsukawa. 2004. Innate immune response in Th1- and Th2-dominant mouse strains. Shock 22: 460-466. (Pubitemid 39472571)
47. Almeida, J. R., D. A. Price, L. Papagno, Z. A. Arkoub, D. Sauce, E. Bornstein, T. E. Asher, A. Samri, A. Schnuriger, I. Theodorou, et al. 2007. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, poly-functionality, and clonal turnover. J. Exp. Med. 204: 2473-2485. (Pubitemid 47529331)
48. Darrah, P. A., D. T. Patel, P. M. De Luca, R. W. B. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850. (Pubitemid 47038186)
49. Kannanganat, S., C. Ibegbu, L. Chennareddi, H. L. Robinson, and R. R. Amara. 2007. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J. Virol. 81: 8468-8476. (Pubitemid 47242819)
50. Adams, W. C., E. Bond, M. J. E. Havenga, L. Holterman, J. Goudsmit, G. B. Karlsson Hedestam, R. A. Koup, and K. Loré. 2009. Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptorindependent receptor pathway mediated by lactoferrin and DC-SIGN. J. Gen. Virol. 90: 1600-1610.
51. Carragher, D. M., D. A. Kaminski, A. Moquin, L. Hartson, and T. D. Randall. 2008. A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. J. Immunol. 181: 4168-4176.
52. Yewdell, J. W., E. Frank, and W. Gerhard. 1981. Expression of influenza A virus internal antigens on the surface of infected P815 cells. J. Immunol. 126: 1814-1819. (Pubitemid 11120964)
53. Germann, T., M. Bongartz, H. Dlugonska, H. Hess, E. Schmitt, L. Kolbe, E. Kölsch, F. J. Podlaski, M. K. Gately, and E. Rüde. 1995. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25: 823-829.
54. Brown, M. P., D. J. Topham, M. Y. Sangster, J. Zhao, K. J. Flynn, S. L. Surman, D. L. Woodland, P. C. Doherty, A. G. Farr, P. K. Pattengale, and M. K. Brenner. 1998. Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice. Nat. Med. 4: 1253-1260. (Pubitemid 28512105)
55. Jain, A., J. A. Kovacs, D. L. Nelson, S. A. Migueles, S. Pittaluga, W. Fanslow, X. Fan, D. W. Wong, J. Massey, R. Hornung, et al. 2011. Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand. Blood 118: 3811-3817.
56. Chougnet, C. 2003. Role of CD40 ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells. J. Leukoc. Biol. 74: 702-709. (Pubitemid 38040346)
57. Zhang, R., J. D. Lifson, and C. Chougnet. 2006. Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions. Blood 107: 1989-1995. (Pubitemid 43289382)
58. Eaton, S. M., E. M. Burns, K. Kusser, T. D. Randall, and L. Haynes. 2004. Agerelated defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J. Exp. Med. 200: 1613-1622. (Pubitemid 40094185)
59. Malaspina, A., S. Moir, S. M. Orsega, J. Vasquez, N. J. Miller, E. T. Donoghue, S. Kottilil, M. Gezmu, D. Follmann, G. M. Vodeiko, et al. 2005. Compromised B cell responses to influenza vaccination in HIV-infected individuals. J. Infect. Dis. 191: 1442-1450. (Pubitemid 40563355)
60. Nabel, G. J., and A. S. Fauci. 2010. Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine. Nat. Med. 16: 1389-1391.
61. Steel, J., A. C. Lowen, T. T. Wang, M. Yondola, Q. Gao, K. Haye, A. García-Sastre, and P. Palese. 2010. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 1: e00018-e10.
62. Breathnach, C. C., H. J. Clark, R. C. Clark, C. W. Olsen, H. G. Townsend, and D. P. Lunn. 2006. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge. Vaccine 24: 1180-1190. (Pubitemid 43202264)
63. Donnelly, J. J., A. Friedman, J. B. Ulmer, and M. A. Liu. 1997. Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination. Vaccine 15: 865-868. (Pubitemid 27287977)
64. Ulmer, J. B., T. M. Fu, R. R. Deck, A. Friedman, L. Guan, C. DeWitt, X. Liu, S. Wang, M. A. Liu, J. J. Donnelly, and M. J. Caulfield. 1998. Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. J. Virol. 72: 5648-5653. (Pubitemid 28283349)
65. Roy, S., G. P. Kobinger, J. Lin, J. Figueredo, R. Calcedo, D. Kobasa, and J. M. Wilson. 2007. Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein. Vaccine 25: 6845-6851. (Pubitemid 47398928)